Trials / Completed
CompletedNCT06122597
A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Trace Minerals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This virtual single-arm trial will last 12 weeks. Participants will take the drops daily and complete questionnaires at Baseline, Week 4, Week 8, and Week 12. Urine pH measurements will be taken at Baseline, Week 4, Week 8, and Week 12 using pH test strips.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ConcenTrace | The product contains concentrated seawater from Utah's inland sea. |
Timeline
- Start date
- 2023-10-05
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2023-11-08
- Last updated
- 2024-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06122597. Inclusion in this directory is not an endorsement.